Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial
Titel:
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial
Auteur:
Atkins, Michael B Plimack, Elizabeth R Puzanov, Igor Fishman, Mayer N McDermott, David F Cho, Daniel C Vaishampayan, Ulka George, Saby Olencki, Thomas E Tarazi, Jamal C Rosbrook, Brad Fernandez, Kathrine C Lechuga, Mariajose Choueiri, Toni K